An Open Label Registry Study of Lutetium-177 (DOTA0, TYR3) Octreotate (Lu-DOTA-TATE) Treatment in Patients with Somatostatin Receptor Positive Tumours
Clinical trial NCT02236910 · UNKNOWN
Trial details
- NCT number
- NCT02236910
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2025-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.